BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35850758)

  • 1. Statistical analysis of correlation of gamma passing results for two quality assurance phantoms used for patient-specific quality assurance in volumetric modulated arc radiotherapy.
    Kunii Y; Tanabe Y; Nakamoto A; Nishioka K
    Med Dosim; 2022 Winter; 47(4):329-333. PubMed ID: 35850758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a quasi-3D dosimeter using radiochromic plastic for patient-specific quality assurance.
    Cho JD; Jin H; Jung S; Son J; Choi CH; Park JM; Kim JS; Kim JI
    Med Phys; 2023 Oct; 50(10):6624-6636. PubMed ID: 37408321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement comparison and Monte Carlo analysis for volumetric-modulated arc therapy (VMAT) delivery verification using the ArcCHECK dosimetry system.
    Lin MH; Koren S; Veltchev I; Li J; Wang L; Price RA; Ma CM
    J Appl Clin Med Phys; 2013 May; 14(2):3929. PubMed ID: 23470927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Volumetric-modulated arc therapy: effective and efficient end-to-end patient-specific quality assurance.
    O'Daniel J; Das S; Wu QJ; Yin FF
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1567-74. PubMed ID: 21470797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective analysis for patient-specific quality assurance of volumetric-modulated arc therapy plans.
    Li G; Wu K; Peng G; Zhang Y; Bai S
    Med Dosim; 2014; 39(4):309-13. PubMed ID: 24958705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the sensitivity of two 3D diode array dosimetry systems to setup error for quality assurance (QA) of volumetric-modulated arc therapy (VMAT).
    Li G; Bai S; Chen N; Henderson L; Wu K; Xiao J; Zhang Y; Jiang Q; Jiang X
    J Appl Clin Med Phys; 2013 Sep; 14(5):13-24. PubMed ID: 24036856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel approach to EPID-based 3D volumetric dosimetry for IMRT and VMAT QA.
    Alhazmi A; Gianoli C; Neppl S; Martins J; Veloza S; Podesta M; Verhaegen F; Reiner M; Belka C; Parodi K
    Phys Med Biol; 2018 May; 63(11):115002. PubMed ID: 29714714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial clinical experience with ArcCHECK for IMRT/VMAT QA.
    Aristophanous M; Suh Y; Chi PC; Whittlesey LJ; LaNeave S; Martel MK
    J Appl Clin Med Phys; 2016 Sep; 17(5):20-33. PubMed ID: 27685107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study on correlation between 2D and 3D gamma evaluation metrics in patient-specific quality assurance for VMAT.
    Rajasekaran D; Jeevanandam P; Sukumar P; Ranganathan A; Johnjothi S; Nagarajan V
    Med Dosim; 2014; 39(4):300-8. PubMed ID: 24910246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method to reconstruct and apply 3D primary fluence for treatment delivery verification.
    Liu S; Mazur TR; Li H; Curcuru A; Green OL; Sun B; Mutic S; Yang D
    J Appl Clin Med Phys; 2017 Jan; 18(1):128-138. PubMed ID: 28291913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between gamma index passing rate and clinical dosimetric difference for pre-treatment 2D and 3D volumetric modulated arc therapy dosimetric verification.
    Jin X; Yan H; Han C; Zhou Y; Yi J; Xie C
    Br J Radiol; 2015 Mar; 88(1047):20140577. PubMed ID: 25494412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Texture analysis on the fluence map to evaluate the degree of modulation for volumetric modulated arc therapy.
    Park SY; Kim IH; Ye SJ; Carlson J; Park JM
    Med Phys; 2014 Nov; 41(11):111718. PubMed ID: 25370632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of plan parameters on the dosimetric accuracy of volumetric modulated arc therapy.
    Masi L; Doro R; Favuzza V; Cipressi S; Livi L
    Med Phys; 2013 Jul; 40(7):071718. PubMed ID: 23822422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Error detection model developed using a multi-task convolutional neural network in patient-specific quality assurance for volumetric-modulated arc therapy.
    Kimura Y; Kadoya N; Oku Y; Kajikawa T; Tomori S; Jingu K
    Med Phys; 2021 Sep; 48(9):4769-4783. PubMed ID: 34101848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical evaluation of the PTW 2D-ARRAY seven29 and OCTAVIUS II phantom for IMRT and VMAT verification.
    Hussein M; Adams EJ; Jordan TJ; Clark CH; Nisbet A
    J Appl Clin Med Phys; 2013 Nov; 14(6):4460. PubMed ID: 24257288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the Acuros XB spatial discretization error on ArcCHECK VMAT QA for small-field SBRT.
    He C; Pant A; Le AH
    J Appl Clin Med Phys; 2023 Sep; 24(9):e14100. PubMed ID: 37563870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of phantom-based and log file patient-specific QA with complexity scores for VMAT.
    Agnew CE; Irvine DM; McGarry CK
    J Appl Clin Med Phys; 2014 Nov; 15(6):4994. PubMed ID: 25493524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the gamma index analysis in various commercial IMRT/VMAT QA systems.
    Hussein M; Rowshanfarzad P; Ebert MA; Nisbet A; Clark CH
    Radiother Oncol; 2013 Dec; 109(3):370-6. PubMed ID: 24100148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative evaluation of 3D dosimetry for stereotactic volumetric-modulated arc delivery using COMPASS.
    Vikraman S; Manigandan D; Karrthick KP; Sambasivaselli R; Senniandavar V; Ramu M; Rajesh T; Lutz M; Muthukumaran M; Karthikeyan N; Tejinder K
    J Appl Clin Med Phys; 2014 Jan; 16(1):5128. PubMed ID: 25679152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study on the effect of detector resolution on gamma index passing rate for VMAT and IMRT QA.
    Woon W; Ravindran PB; Ekayanake P; S V; Lim YY; Khalid J
    J Appl Clin Med Phys; 2018 Mar; 19(2):230-248. PubMed ID: 29460465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.